Dietary wolfberry supplementation enhances the protective effect of flu vaccine against influenza challenge in aged mice

Journal of Nutrition

Volumn 144, Issue 2, 2014, Pages 224-229

  Du, Xiaogang ^a   Wang, Junpeng ^a   Niu, Xinli ^a   Smith, Donald ^a   Wu, Dayong ^a   Meydani, Simin Nikbin ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; INFLUENZA VACCINE; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 4; LYCIUM EXTRACT; OVALBUMIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFICACY; DRUG POTENTIATION; HEMAGGLUTINATION INHIBITION; HISTOCOMPATIBILITY COMPLEX; IN VITRO STUDY; INFLUENZA A; INFLUENZA VACCINATION; LYCIUM; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; BONE MARROW; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; DIETARY SUPPLEMENTS; ENDOCYTOSIS; FRUIT; GENES, MHC CLASS II; IMMUNIZATION; INFLUENZA A VIRUS; INFLUENZA VACCINES; LYCIUM; MALE; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; OVALBUMIN; PEPTIDE FRAGMENTS; PHYTOTHERAPY; PLANT PREPARATIONS; WEIGHT LOSS;

EID: 84892658322     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.183566     Document Type: Article

References (36)

1. Crossley KB, Peterson PK. Infections in the elderly. Clin Infect Dis. 1996;22:209-15.
2. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis. 2002;2:659-66.
3. Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis. 2000;30:931-3.
4. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-40.
5. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008;320:340-6.
6. Stöhr K. Influenza-WHO cares. Lancet Infect Dis. 2002;2:517.
7. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-86.
8. Aw D, Silva A, Palmer D. Immunosenescence: emerging challenges for an ageing population. Immunology. 2007;120:435-46.
9. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004;5:133-9.
10. Pawelec G. Immunity and ageing in man. Exp Gerontol. 2006;41:1239-42. 11. McElhaney JE. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine. 2005;23: Suppl 1:S10-25.
11. McElhaney JE. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine. 2005;23: Suppl 1:S10-25.
12. Reber AJ, Chirkova T, Kim JH, Cao W, Biber R, Shay DK, Sambhara S. Immunosenescence and challenges of vaccination against influenza in the aging population. Aging Dis. 2012;3:68-90.
13. Webster RG. Immunity to influenza in the elderly. Vaccine. 2000;18: 1686-9.
14. Weinberger B, Grubeck-Loebenstein B. Vaccines for the elderly. Clin Microbiol Infect. 2012;18 Suppl 5:100-8.
15. Liu WM, van der Zeijst BA, Boog CJ, Soethout EC. Aging and impaired immunity to influenza viruses: implications for vaccine development. Hum Vaccin. 2011;7: Suppl:94-8.
16. Grubeck-Loebenstein B, Della Bella S, Iorio AM, Michel JP, Pawelec G, Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res. 2009;21:201-9.
17. Li XM, Ma YL, Liu XJ. Effect of the Lycium barbarum polysaccharides on age-related oxidative stress in aged mice. J Ethnopharmacol. 2007; 111:504-11.
18. Lin CL, Wang C, Chang S, Inbaraj B, Chen B. Antioxidative activity of polysaccharide fractions isolated from Lycium barbarum Linnaeus. Int J Biol Macromol. 2009;45:146-51.
19. Yu MS, Leung S, Lai S, Che C, Zee S, So K, Yuen W, Chang R. Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity. Exp Gerontol. 2005; 40:716-27.
20. Gan L, Zhang S-H, Liu Q, Xu H-B. A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells. Eur J Pharmacol. 2003;471:217-22.
21. Chen JR, Li EQ, Dai CQ, Yu B, Wu XL, Huang CR, Chen XY. The inducible effect of LBP on maturation of dendritic cells and the related immune signaling pathways in hepatocellular carcinoma (HCC). Curr Drug Deliv. 2012;9:414-20.
22. Chen Z, Lu J, Srinivasan N, Tan BKH, Chan SH. Polysaccharideprotein complex from Lycium barbarum L. is a novel stimulus of dendritic cell immunogenicity. J Immunol. 2009;182:3503-9.
23. Ren Z, Na L, Xu Y, Rozati M, Wang J, Xu J, Sun C, Vidal K, Wu D, Meydani SN. Dietary supplementation with lacto-wolfberry enhances the immune response and reduces pathogenesis to influenza infection in mice. J Nutr. 2012;142:1596-602.
24. Vidal K, Benyacoub J, Sanchez-Garcia J, Foata F, Segura-Roggero I, Serrant P, Moser M, Blum S. Intake of a milk-based wolfberry formulation enhances the immune response of young-adult and aged mice. Rejuvenation Res. 2010;13:47-53.
25. Vidal K, Bucheli P, Gao Q, Moulin J, Shen L, Wang J, Blum S, Benyacoub J. Immunomodulatory effects of dietary supplementation with a milk-based wolfberry formulation in healthy elderly: a randomized, double-blind, placebo-controlled trial. Rejuvenation Res. 2012;15: 89-97.
26. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-51.
27. Wen Z, Ye L, Gao Y, Pan L, Dong K, Bu Z, Compans R, Yang C. Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge. Antiviral Res. 2009;84: 215-24.
28. Agarwal S, Busse PJ. Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol. 2010;104:183-90; quiz 90-2, 210.
29. Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. 2009;22:1041-50.
30. Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, Lord JM, Shaw AC. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol. 2009;30:325-33.
31. Gardner EM, Gonzalez E, Nogusa S, Murasko D. Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. Vaccine. 2006;24:1609-14.
32. Kovaiou RD, Herndler-Brandstetter D, Grubeck-Loebenstein B. Agerelated changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med. 2007;9:1-17.
33. Kumar R, Burns EA. Age-related decline in immunity: implications for vaccine responsiveness. Expert Rev Vaccines. 2008;7:467-79.
34. Zhu J, Zhao LH, Zhao XP, Chen Z. Lycium barbarum polysaccharides regulate phenotypic and functional maturation of murine dendritic cells. Cell Biol Int. 2007;31:615-9.
35. Potterat O. Goji (Lycium barbarum and L. chinense): phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity. Planta Med. 2010;76:7-19.
36. Peng X, Tian G. Structural characterization of the glycan part of glycoconjugate LbGp2 from Lycium barbarum L. Carbohydr Res. 2001;331:95-9. Wolfb